X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5827) 5827
Publication (379) 379
Book / eBook (261) 261
Book Review (92) 92
Book Chapter (90) 90
Newsletter (16) 16
Conference Proceeding (12) 12
Reference (6) 6
Web Resource (6) 6
Data Set (1) 1
Magazine Article (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5066) 5066
index medicus (2978) 2978
male (2774) 2774
female (2686) 2686
central-nervous-system (2109) 2109
adult (1915) 1915
clinical neurology (1912) 1912
magnetic resonance imaging (1810) 1810
middle aged (1791) 1791
central nervous system (1760) 1760
oncology (1372) 1372
diagnosis (1236) 1236
aged (1147) 1147
surgery (1096) 1096
tumors (1075) 1075
child (1069) 1069
brain (1066) 1066
adolescent (1012) 1012
medicine & public health (912) 912
neurosciences (882) 882
nervous system (874) 874
tomography, x-ray computed (812) 812
radiology, nuclear medicine & medical imaging (808) 808
diagnosis, differential (785) 785
cancer (784) 784
brain neoplasms - pathology (760) 760
neurology (733) 733
retrospective studies (716) 716
child, preschool (646) 646
pathology (639) 639
chemotherapy (631) 631
brain neoplasms - diagnostic imaging (600) 600
pediatrics (587) 587
radiotherapy (578) 578
neurosurgery (573) 573
treatment outcome (573) 573
care and treatment (572) 572
brain neoplasms - diagnosis (550) 550
patients (548) 548
prognosis (541) 541
children (522) 522
infant (519) 519
diseases (518) 518
brain tumors (512) 512
neoplasms (487) 487
young adult (465) 465
research (464) 464
gliomas (461) 461
animals (457) 457
medicine (447) 447
neuroimaging (436) 436
brain - pathology (435) 435
therapy (421) 421
lymphomas (410) 410
central nervous system neoplasms - pathology (408) 408
radiology (401) 401
central nervous system neoplasms - diagnosis (394) 394
health aspects (385) 385
magnetic resonance imaging - methods (378) 378
radiography (368) 368
immunohistochemistry (359) 359
aged, 80 and over (351) 351
metastasis (348) 348
analysis (339) 339
biopsy (326) 326
risk factors (326) 326
survival (322) 322
hematology (320) 320
brain neoplasms - surgery (318) 318
body (315) 315
brain cancer (313) 313
organs (311) 311
radiology and nuclear medicine (300) 300
diagnostic imaging (299) 299
glioma (298) 298
lymphoma (292) 292
follow-up studies (291) 291
brain-tumors (283) 283
neuroradiology (283) 283
mri (281) 281
combined modality therapy (279) 279
primary cns lymphoma (270) 270
glioblastoma (268) 268
classification (267) 267
medical imaging (264) 264
brain - diagnostic imaging (263) 263
radiation-therapy (258) 258
central nervous system diseases (255) 255
central nervous system neoplasms - therapy (254) 254
brain neoplasms - therapy (253) 253
management (251) 251
central nervous system neoplasms - diagnostic imaging (250) 250
diagnostic techniques (250) 250
tomography (250) 250
nuclear magnetic resonance--nmr (232) 232
radiation (232) 232
nervous system diseases (230) 230
usage (228) 228
radiation therapy (227) 227
lesions (223) 223
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (172) 172
Collection Dvlpm't (Acquisitions) - Closed Orders (16) 16
Collection Dvlpm't (Acquisitions) - Vendor file (16) 16
Online Resources - Online (16) 16
UofT at Mississauga - Stacks (10) 10
St. Michael's Hospital - Stacks (7) 7
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (7) 7
Holland Bloorview Kids Rehabilitation - Stacks (5) 5
UofT at Scarborough - Stacks (5) 5
Baycrest Hospital - Stacks (4) 4
Scarborough Hospital - General (4) 4
Lakeridge Health Sciences - Oshawa (3) 3
Providence Healthcare - Stacks (3) 3
Scarborough Hospital - Birchmount (3) 3
Sunnybrook Health Sciences Centre - Sunnybrook Reference (3) 3
UTL at Downsview - May be requested (3) 3
Credit Valley Hospital - Reserve desk (2) 2
Credit Valley Hospital - Stacks (2) 2
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (2) 2
Gerstein Science - Circulation Desk (2) 2
Gerstein Science - Missing (2) 2
Humber River Regional Hospital - Finch Stacks (2) 2
Providence Healthcare - Reference (2) 2
Stacks (2) 2
Trillium Health Centre - Stacks (2) 2
West Park Healthcare Centre - Stacks (2) 2
Baycrest Hospital - Course Reserves (1) 1
Chemistry (A D Allen) - Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Reference (1) 1
Dentistry (Harry R Abbott) - Stacks (1) 1
Dentistry (Harry R Abbott) - Withdrawn (1) 1
Earth Sciences (Noranda) - Missing (1) 1
Gerstein Science - Course Reserves (1) 1
Gerstein Science - Reference Desk (1) 1
Humber River Regional Hospital - Church Stacks (1) 1
Missing (1) 1
Regis College - Stacks (1) 1
Robarts - Reference (1) 1
Scarborough Hospital - Closed Orders (1) 1
St Josephs Health Centre - General (1) 1
St Josephs Health Centre - Reference (1) 1
St Josephs Health Centre - Stacks (1) 1
St. Michael's College (John M. Kelly) - Circulation Desk (1) 1
St. Michael's Hospital - Circulation Desk (1) 1
St. Michael's Hospital - Online (1) 1
Sunnybrook Health Sciences Centre - Online (1) 1
Toronto East General Hospital - Stacks (1) 1
Trillium Health Centre - Reserve desk (1) 1
Trinity College (John W Graham) - Stacks (1) 1
University College (Laidlaw) - Stacks (1) 1
Victoria University E.J. Pratt - Reference (1) 1
Women's College Hospital - Pharmacy (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6022) 6022
Spanish (38) 38
French (35) 35
German (28) 28
Japanese (16) 16
Chinese (11) 11
Portuguese (10) 10
Russian (6) 6
Polish (5) 5
Hungarian (4) 4
Czech (3) 3
Italian (3) 3
Norwegian (3) 3
Danish (2) 2
Slovak (2) 2
Swedish (2) 2
Turkish (2) 2
Dutch (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Clinical Cancer Research, ISSN 1078-0432, 06/2017, Volume 23, Issue 12, pp. e46 - e53
Although the neurofibromatoses consist of at least three autosomal dominantly inherited disorders, neurofibromatosis 1 (NF1), neurofibromatosis 2 (NF2), and... 
GENOTYPE-PHENOTYPE CORRELATION | WHOLE-BODY MRI | FAMILIAL SCHWANNOMATOSIS | POSITRON-EMISSION-TOMOGRAPHY | VONRECKLINGHAUSEN NEUROFIBROMATOSIS | GENETIC-LINKAGE | PLEXIFORM NEUROFIBROMAS | ONCOLOGY | SHEATH TUMORS | TYPE-1 NF1 | MISMATCH REPAIR DEFICIENCY | Skin Neoplasms - diagnostic imaging | Skin Neoplasms - therapy | Central Nervous System Neoplasms - genetics | Humans | Neurilemmoma - diagnostic imaging | Neurofibromatosis 1 - diagnostic imaging | Optic Nerve Glioma - genetics | Central Nervous System Neoplasms - therapy | Infant | Optic Nerve Glioma - diagnostic imaging | Neurofibromatoses - genetics | Neurofibromatosis 1 - therapy | Optic Nerve Glioma - therapy | Magnetic Resonance Imaging | Neurilemmoma - therapy | Neurilemmoma - genetics | Central Nervous System Neoplasms - diagnostic imaging | Skin Neoplasms - genetics | Adolescent | Neurofibromatosis 1 - genetics | Child | Neurofibromatoses - diagnostic imaging | Neurofibromatoses - therapy | Pediatrics | Leukemia | Brain tumors | Central nervous system | Parents | Rhabdomyosarcoma | Neurofibromin 2 | Neurofibromatosis 2 | Cognition | Malignancy | Genetic screening | Risk factors | Osteoprotegerin | Children | Astrocytoma | Myelomonocytic leukemia | Organs | Health risks | Recklinghausen's disease | Morbidity | Hereditary diseases | Magnetic resonance imaging | Surveillance | Glioma | Neurofibromatosis | Diagnostic systems | Cancer | Tumors
Journal Article
Journal Article
Journal Article
Journal Article
Journal Article
Brain Pathology, ISSN 1015-6305, 09/2018, Volume 28, Issue 5, pp. 710 - 720
Central nervous system high‐grade neuroepithelial tumors with BCOR alteration (CNS HGNET‐BCOR) are a recently reported rare entity, identified as a small... 
BCOR ITD | clear cell sarcoma of the kidney | high‐grade neuroepithelial tumor | high-grade neuroepithelial tumor | GLIOMAS | CLEAR-CELL-SARCOMA | PATHOLOGY | CHILDHOOD | NEUROSCIENCES | IMMUNOHISTOCHEMICAL MARKER | CLINICAL NEUROLOGY | SIOP | ENTITY | CENTRAL-NERVOUS-SYSTEM | FUSIONS | INFANCY | Brain - diagnostic imaging | Kidney - pathology | Exons | Humans | Child, Preschool | Infant | Male | Segmental Duplications, Genomic | Kidney Neoplasms - metabolism | Neoplasms, Neuroepithelial - pathology | Young Adult | Kidney - metabolism | Oligodendrocyte Transcription Factor 2 - metabolism | Neoplasms, Neuroepithelial - genetics | Female | Child | Central Nervous System Neoplasms - metabolism | Central Nervous System Neoplasms - genetics | Repressor Proteins - genetics | Proto-Oncogene Proteins - genetics | Sarcoma - pathology | Neoplasms, Neuroepithelial - metabolism | Sarcoma - metabolism | Central Nervous System Neoplasms - pathology | Central Nervous System Neoplasms - diagnostic imaging | Neoplasms, Neuroepithelial - diagnostic imaging | Kidney Neoplasms - pathology | Chromatin | Sarcoma | Gliomas | Analysis | Nerve proteins | Stem cells | Synaptophysin | Nervous system diseases | Kidneys | Mesenchyme | Brain tumors | Glial fibrillary acidic protein | Cytology | Central nervous system | Olig2 protein | Staining | Necrosis | Proteins | Glioma | Reproduction (copying) | Morphology | Nuclei (cytology) | Tumors
Journal Article
Lancet Haematology, The, ISSN 2352-3026, 2016, Volume 3, Issue 5, pp. e217 - e227
Summary Background Standard treatment for patients with primary CNS lymphoma remains to be defined. Active therapies are often associated with increased risk... 
Hematology, Oncology and Palliative Medicine | 1ST-LINE TREATMENT | RESPONSE CRITERIA | GUIDELINES | NON-HODGKINS-LYMPHOMA | FOLLOW-UP | CENTRAL-NERVOUS-SYSTEM | WHOLE-BRAIN RADIOTHERAPY | HIGH-DOSE CHEMOTHERAPY | STEM-CELL TRANSPLANTATION | HEMATOLOGY | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Lymphoma, B-Cell - therapy | Middle Aged | Male | Comparative Effectiveness Research | Hyperglycemia - chemically induced | Radiotherapy, Adjuvant - adverse effects | Hematopoietic Stem Cell Transplantation - adverse effects | Lymphoma, B-Cell - diagnostic imaging | Transplantation Conditioning - methods | Rituximab - adverse effects | Induction Chemotherapy - methods | Anemia - chemically induced | Central Nervous System Neoplasms - therapy | Thrombocytopenia - chemically induced | Mucositis - chemically induced | Magnetic Resonance Imaging | Methotrexate - adverse effects | Dexamethasone - therapeutic use | Radiotherapy, Adjuvant - methods | Transplantation, Autologous - adverse effects | Heart Injuries - chemically induced | Italy | Hematopoietic Stem Cell Transplantation - methods | Central Nervous System Neoplasms - mortality | Germany | Thiotepa - adverse effects | Thiotepa - therapeutic use | Thrombosis - chemically induced | Intraocular Lymphoma - therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Infection - chemically induced | Rituximab - therapeutic use | Stroke - chemically induced | Optic Nerve Neoplasms - diagnostic imaging | Poisoning - epidemiology | Female | Remission Induction - methods | Transplantation Conditioning - adverse effects | Acute Kidney Injury - chemically induced | Neutropenia - chemically induced | Optic Nerve Neoplasms - therapy | Death, Sudden - epidemiology | Lymphoma, B-Cell - mortality | Intraocular Lymphoma - diagnostic imaging | Kaplan-Meier Estimate | Chemical and Drug Induced Liver Injury - epidemiology | Treatment Outcome | United Kingdom | Combined Modality Therapy - adverse effects | Switzerland | Induction Chemotherapy - adverse effects | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Central Nervous System Neoplasms - diagnostic imaging | Denmark | Combined Modality Therapy - methods | Neurotoxicity Syndromes - epidemiology | Gastrointestinal Diseases - chemically induced
Journal Article
Journal Article
Leukemia, ISSN 0887-6924, 2017, Volume 31, Issue 12, pp. 2623 - 2629
To investigate safety and efficacy of high-dose chemotherapy followed by autologous stem cell transplantation (HCT-ASCT) in relapsed/refractory (r/r) primary... 
1ST-LINE TREATMENT | INTENSIVE CHEMOTHERAPY | ONCOLOGY | RECURRENT PRIMARY CNS | CLINICAL-TRIALS | PHASE-II | INTRAOCULAR LYMPHOMA | SALVAGE THERAPY | FOLLOW-UP | CENTRAL-NERVOUS-SYSTEM | HEMATOLOGY | TRANSPLANTATION | Recurrence | Brain - diagnostic imaging | Prospective Studies | Lymphoma - diagnostic imaging | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Drug Resistance, Neoplasm | Male | Transplantation, Autologous | Lymphoma - mortality | Lymphoma - therapy | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Lymphoma - pathology | Central Nervous System Neoplasms - therapy | Treatment Outcome | Combined Modality Therapy | Retreatment | Central Nervous System Neoplasms - pathology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Central Nervous System Neoplasms - diagnostic imaging | Brain - pathology | Aged | Hematopoietic Stem Cell Transplantation - methods | Central Nervous System Neoplasms - mortality | Chemotherapy | Care and treatment | Patient outcomes | Nervous system cancer | Stem cells | Development and progression | Lymphomas | Transplantation | Methods | Cancer | Brain | Autografts | Central nervous system | Stem cell transplantation | Rituximab | Radiation therapy | Patients | Survival | Lymphoma | Cytarabine | Salvage | Comparative studies | Remission | Methotrexate
Journal Article